Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Levetiracetam for Febrile Convulsions
NCT05860153Unknown
- Sponsor
- Assiut University
- Start
- Jun 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of levetiracetam in febrile seizures (FS) (2 arms), sponsored by Assiut University. Primary endpoints: Rate of therapeutic effect on febrile convulsions at 12 months and Seizure frequency associated with febrile events at 12 months. Status: unknown.
02
Drugs
levetiracetam
03
Conditions
febrile seizures (FS)
Beyond the preview
Go deeper on NCT05860153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05860153.